SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-097013
Filing Date
2023-12-19
Accepted
2023-12-19 17:21:07
Documents
14
Period of Report
2023-12-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea190360-8k_pasithea.htm   iXBRL 8-K 45530
2 PASITHEA THERAPEUTICS CORP. 2023 STOCK INCENTIVE PLAN ea190360ex10-1_pasithea.htm EX-10.1 143274
  Complete submission text file 0001213900-23-097013.txt   446792

Data Files

Seq Description Document Type Size
3 XBRL DEFINITION FILE ktta-20231219_def.xml EX-101.DEF 26681
4 XBRL LABEL FILE ktta-20231219_lab.xml EX-101.LAB 36819
5 XBRL PRESENTATION FILE ktta-20231219_pre.xml EX-101.PRE 25305
6 XBRL SCHEMA FILE ktta-20231219.xsd EX-101.SCH 3810
8 EXTRACTED XBRL INSTANCE DOCUMENT ea190360-8k_pasithea_htm.xml XML 5435
Mailing Address 2110 NARCISSUS CT VENICE CA 90291
Business Address 2110 NARCISSUS CT VENICE CA 90291 8184226172
Pasithea Therapeutics Corp. (Filer) CIK: 0001841330 (see all company filings)

IRS No.: 851591963 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40804 | Film No.: 231498517
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)